SUDEEP PHARMA
Back to Income Statement
|
SUDEEP PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹139 Cr | ₹13 Cr | ₹62 Cr | ₹502 Cr | ₹33 Cr |
What is the latest Consolidated Net Profit of SUDEEP PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹139 Cr |
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹502 Cr |
| Mar2022 | ₹33 Cr |
How is Consolidated Net Profit of SUDEEP PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 941.59 | |
| Mar2025 | ₹13 Cr | -78.63 | |
| Mar2024 | ₹62 Cr | -87.58 | |
| Mar2023 | ₹502 Cr | 1,404.62 | |
| Mar2022 | ₹33 Cr | - | |
Compare Consolidated Net Profit of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹12,851.4 Cr | -5.1% | 0.6% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -5.1% |
0.6% |
|
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses